Haematological Disorders Responsible for Maternal Bleeding in Late Pregnancy

Evans P.C. Obstetric and gynecology patients with vonWillebrand's disease. Obstet Gynecol 1971; 38, 1: 37–43.

Pritchard J.A. Medical and surgical illnesses during pregnancy and the puerperium: Hematologic disorders. In: Williams Obstetrics, Pritchard JA, Macdonald PC, Gant NF, eds. 17th Ed. Apple Century Crofts 1985; 28: 575–580.

Lipton R.D. , Ayromlooi J. , Coller B.S. Severe von Willebrand's disease during labor and delivery. JAMA 1982; 248, 11: 1355–7.

Romero R. The management of acquired hemostatic failure during pregnancy. In: Critical Care of the Obstetric Patient, Berkowitz RL, ed. First Ed. Churchill Livingstone, New York 1983; 9: 219–284.

James M.F. , Wheeler A.S. In: Obstetric Anaesthesia: the Complicated Patient, James M.F. , Wheeler A.S. eds. FA Davis, Philadelphia 1982; 235–238.

Noller K.L. , Bowie E.J. , Kampers R.D. , Owen C.A. vonWillebrand's disease in pregnancy. Obstet Gynecol 1973; 41: 865.

Leone G. , Moneta E. , Paparatti G. , Boni P. vonWillebrand's disease in pregnancy. N Engl J Med 1975; 293: 9, 456.

Bonnar J. Venous Thromboembolism and Pregnancy. In: Recent advances in obstetrics and gynecology No 13. Stallworthy J. , Bourne G. eds, Churchill Livingston, New York, 1979.

Bennet B. , Oxnar S.C. , Douglas A.S. , Ratnoff O.D. Studies on Antihemophilic Factor (AHF, Factor VIII) during labor in normal women, in patients with premature separation of the placenta, and in a patient with vonWillebrand's disease. J Lab Clin Med 1974; 84: 851.

van Royen E.A. , Flier OThN , TenCate J.W. von Willebrand-Factor activity in pregnancy:Lancet 1974; 657.

Haemophilia Therapy Review Committee of NSW: Guidelines on the use of Plasma Component Therapy in Haemophilia and vonWillebrand's Disease, Health Information and Translation Services. ISSN 0314-8025, Department of Health, NSW 1989.

Robertson J.D. Influence of Hepatic Disease on Pregnancy. In: General Anaesthesia, Vol 2, Clinical Practice, Cecil Gray T, Nunn JF, eds. 3rd Ed. Butterworths, London 1976; 9: 118–128.

Delshammar M. , Lasson A. , Nisson I.M. , Ohlsson K. , Wallmark A. , Vernersson E. Abnormal proteolysis (DIC) — Successful treatment with antithrombin III concentrate and a concentrate containing Factor XIII and native von Willebrand Factor. J Int Med 1989; 225: 21–27.

Wilde J.T. , Kitchen S. , Kinsey S. , Greaves M. , Preston F.E. (Plasma D-dimer levels and their relationship to severe fibrinogen/fibrin degradation products in hypercoagulable states. Br J Haematol 1989; 71: 65–70.

Cines D.B. , Dusak B. , Tomasaki A. Immune Thrombocytopenic purpura and pregnancy. N Engl J Med 1982; 306: 826.

Ness P.M. , Perkins H.A. Cryoprecipitate as a reliable source of fibrinogen replacement. JAMA 1979; 241, 16: 1690–91.

Laros R.K. Coagulation disorders in the obstetric and surgical patient. In: Anesthesia for Obstetrics, Shnider SM, Levinson G, eds. 1st Ed. Williams & Wilkins, Baltimore 1979; 235–242.

Ellison N. , Jobes- D.R. Diagnosis of disorders of haemostasis. In: ASA Refresher Courses in Anaesthesiology, Weiss JB, ed. Lippincott, Philadelphia 1979; 7: 93–94.

Petit Cr , Klein H.G. Haemophilia, haemophiliacs and the Health Care System. In: NIH 76–871, 31.

Conn H.F. In: Current Therapy, WB Saunders, Philadelphia, 1982.

Thomas D. Haparin in prophylaxis and treatment of venous thromboembolism. Seminar Haematol 1987; 15: 1

Aldrete J.A. , Guerra F. Hematologic Diseases in Anesthesia and Uncommon Diseases. Katz J. , Benumof J. , Kadis L.B. eds. 2nd Ed. Saunders, Philadelphia 1981; 313–383.

O'Reilly R.A. Anticoagulant, antithrombotic and thrombolytic drugs. In: The Pharmacological Basis of Therapeutics. Gillman A.C. , Goodman L.S. , Gilman A. eds. 6th Ed. Macmillan, New York, 1980; 1350–1366.

Bromage P.R. Continuous epidural analgesia. In: Epidural Analgesia Bromage PR ed. 1st Ed. Saunders, Philadelphia 1978; 7: 215–257.

Bull M.H. , Huse W.M. , Bull B.S. Evaluation of tests to monitor heparin therapy during extracorporeal circulation. Anesthesiology 1975; 43: 346–353.

Lowenstein E. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin, Anesthesiology 1983; 59: 470–3.

Oh T.E. Coagulation disorders. In: Intensive Care Manual, Oh TE ed. 1st Ed. Butterworths, Sydney 1981; 58: 230–232.

Fischbach D.P. , Fogdall R.P. In: Coagulation: The Essentials, Williams and Wilkins 1980; 69.

Rush B. , Lee N.Y.L. Clinical presentation of non-haemolytic transfusion reactions. Anesth Intens Care 1980; 8: 125–131.

Webster B.H. Clinical presentation of haemolytic transfusion reactions, Anesth Intens Care 1980; 8: 115–119.

Miller R.D. Complications of Massive Blood Tranfusions. Anesthesiology 1973; 39: 82–93.

Burrow Ferris . In: Medical Complications in Pregnancy, Burrow G.N. , Ferris T.F. eds. WB Saunders, Philadelphia 1982; 280.

Strunin L. Drugs and the Liver. In: The Liver and Anaesthesia Major Problems in Anaesthesia. Strunin L ed. 1st Ed. Saunders, London 1977; 3: 60–68.

Harper M.H. , Collins P. , Johnson B. , Eger El , Biava C. Hepatic injury following halothane, enflurane and isoflurane anesthesia in rats. Anesthesiology 1982; 56: 14–17.

Kelton J.G. , Cruickshank M. Hematologic disorders of pregnancy. In: Critical Care of the Obstetric Patient, Ch 3, Berkowitz R.L. ed. 1st Ed. Churchill Livingston, New York 1983; Ch 3: 65–94.

National Blood Resource Education Program Expert Panel on the Indications for the Use of Red Blood Cells, Platelets and Fresh Frozen Plasma. In: Transfusion Alert, NIH Publication No 89-2974a, US Dept of Health and Human Services, 1989.

Office of Medical Applications of Research, National Institute of Health: Perioperative Red Cell Transfusion, JAMA 1988; 260: 18: 270–3.

Scott J.R. , Rote N.S. , Cruickshank D.P. Antiplatelet antibodies and platelet counts in pregnancies complicated by autoimmune thrombocytopenic purpura. Am J Obstet Gynecol 1983; 145, 8: 932–9.

Harrison K.L. , Bramich L. , Collins K.A. Platelet count during normal pregnancy. Aust NZ J Obstet Gynaecol 1982; 22: 74–75.

Payne B.A. , Pierre R.V. Pseudothrombocytopenia: A laboratory artifact with potentially serious consequences. Mayo Clin Proc 1984; 59: 123.

Schindler M. , Gatt S. , Isert P. , Morgans D. , Cheung A. Thrombocytopenia and platelet defects. In: Preeclampsia: Implications for regional anaesthesia. Anaesth Intens Care 1990.

Kelton J.G. , Meltzer D. , Moore J. . Drug–induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood 58; 524, 19.

Hackett T. , Kelton J.G. , Powers P. Drug induced platelet destruction. Semin Thromb Hemost 1982; 8: 116.

King D.J. , Kelton J.G. Heparin associated thrombocytopenia. Ann Int Med 1984; 100: 535.

Kelton J.G. , Gibbons S. Immune thrombocytopenia. Semin Thromb Hemost 1982; 8: 835.

Kelton J.G. Management of the pregnant patient with idiopathic thrombocytopenic purpura. Ann Int Med 1983; 99: 796.

Adderley R.J. , Rogers P.C.J. , Shaw D. . High dose intravenous therapy with immune globulin before delivery for idiopathic thrombocytopenic purpura. Can Med Assoc J, 1984; 130: 894.

Stirling Y. , Woolf L. , North W.R.S. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176.

Karpatkin S. Autoimmune thrombocytopenic purpura, Blood 1980; 56: 329.